Non classé
Ponsegromab: A New Hope for Cancer Cachexia Treatment
Cancer cachexia, a severe wasting syndrome often experienced by patients with advanced cancer, leads to substantial weight loss, muscle wasting, an...
Empowering Patient Voices at the National Congress of Medical Oncology
I am thrilled to share my experience of being invited to speak at the National Congress of Medical Oncology opening ceremony. This prestigious even...
Zorana Maravic, DiCE CEO, Co-Chairs Global Effort for Medicine Accessibility
In an inspiring move toward global healthcare improvement, Zorana Maravic, CEO of Digestive Cancers Europe (DiCE), took centre stage as co-chair of...
New Era in Gastric Cancer Treatment: Zolbetuximab Gains EU Approval
On September 20th, 2024, the European Commission approved zolbetuximab with chemotherapy for advanced Gastric and GastroEsophageal Junction cancers...
Hepatocellular Carcinoma Prevention & Diagnosis: DiCE Publishes Project Results
DiCE’s mapping research project on HCC prevention and diagnosis in Europe reveals rising incidence and mortality rates. The results, published du...
DiCE Attends the TOGAS EU Project Consortium Meeting and Conference
Zorana Maravic, our CEO, and Ana Martins participated in the TOGAS Consortium Meeting and TOGAS Conference on 11-12 September at Fundação Eng. An...
DiCE Attends The Horizon Europe Cancer Mission ‘Diagnosis and Treatment’ Cluster Meeting
On September 12th in sunny Barcelona, DiCE, a member of the SAGITTARIUS EU Project, participated in the Horizon Europe Cancer Mission’s ‘Diagno...
Rising Liver Cancer Mortality in Europe Linked to Hepatitis B and C Infections Amidst Variance in Prevention and Treatment
Primary liver cancer is the sixth most common cause of cancer-related deaths in Europe. Infection with hepatitis B or C is one of the main risk fac...
DiCE’s Report from the AMMF Annual Cholangiocarcinoma Conference
The Alan Moremont Memorial Fund (AMMF) is the UK’s Cholangiocarcinoma charity. Its annual conference brings together UK and international experts...
DiCE Elevates Patient Advocacy Skills at WECAN Academy in Barcelona
Digestive Cancers Europe (DiCE) had the incredible opportunity to attend the WECAN Academy in the sunny city of Barcelona. Our goal at DiCE is to e...
